SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-17-168636
Filing Date
2017-05-12
Accepted
2017-05-12 16:22:47
Documents
3
Effectiveness Date
2017-05-12

Document Format Files

Seq Description Document Type Size
1 8-K d384310d8k.htm DEFA14A 16883
2 EX-99.1 d384310dex991.htm EX-99.1 13741
3 GRAPHIC g384310ex991pg01.jpg GRAPHIC 16235
  Complete submission text file 0001193125-17-168636.txt   54303
Mailing Address UNIT 5, SRAGH TECHNOLOGY PARK RAHAN ROAD TULLAMORE , CO. OFFALY L2 R35 FR98
Business Address UNIT 5, SRAGH TECHNOLOGY PARK RAHAN ROAD TULLAMORE , CO. OFFALY L2 R35 FR98 353 1 215 8100
Nexvet Biopharma plc (Filer) CIK: 0001618561 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 0630
Type: DEFA14A | Act: 34 | File No.: 001-36828 | Film No.: 17838967
SIC: 2834 Pharmaceutical Preparations